Curaleaf Holdings (CURLF) EBT Growth (1y) (2020 - 2026)
Curaleaf Holdings (CURLF) EBT Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 48.64% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -1.94% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -24.84% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 1,578.91% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 262.69% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 45.00% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -342.95% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 62.03% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 248.00% |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | -74.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -74.57% |
| Dec 31, 2025 | -32,967.43% |
| Sep 30, 2025 | -106.31% |
| Jun 30, 2025 | -111,897.44% |
| Mar 31, 2025 | -42.77% |
| Dec 31, 2024 | 99.88% |
| Sep 30, 2024 | 67.23% |
| Jun 30, 2024 | 30.34% |
| Mar 31, 2024 | -264.90% |
| Dec 31, 2023 | -24,226.20% |
| Sep 30, 2023 | -520.56% |
| Jun 30, 2023 | -177.23% |
| Mar 31, 2023 | -114.72% |
| Dec 31, 2022 | -517.31% |
| Sep 30, 2022 | 223.70% |
| Jun 30, 2022 | -7.11% |
| Mar 31, 2022 | 34.58% |
| Dec 31, 2021 | -888.52% |
| Sep 30, 2021 | -73.09% |
| Jun 30, 2021 | 193.56% |